Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902664-25-005028
Filing Date
2025-11-14
Accepted
2025-11-14 16:16:06
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 7070
  Complete submission text file 0000902664-25-005028.txt   8931
Mailing Address 155 BOVET RD., SUITE 303 SAN MATEO CA 94402
Business Address 155 BOVET RD., SUITE 303 SAN MATEO CA 94402 (650) 561-8600
Sagimet Biosciences Inc. (Subject) CIK: 0001400118 (see all company filings)

EIN.: 205991472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-94156 | Film No.: 251486496
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 4 EMBARCADERO CENTER SUITE 3450 SAN FRANCISCO CA 94111
Business Address 4 EMBARCADERO CENTER SUITE 3450 SAN FRANCISCO CA 94111 415-801-4550
Woodline Partners LP (Filed by) CIK: 0001784547 (see all company filings)

EIN.: 831749088 | State of Incorp.: DE
Type: SCHEDULE 13G/A